Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | AmeriHealth | High Osmolar Contrast AgentsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA09-005 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | High-Frequency Chest Wall Oscillation DevicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-001 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Hematopoietic Stem Cell TransplantationPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-002 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Heating Pads and Heat LampsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-029 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Hair Transplants and Cranial Prostheses (Wigs)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-046 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Guselkumab (Tremfya) Injection for Intravenous UsePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-179 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ground Ambulance Transport Services (Emergency and Nonemergency)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA12-002 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Golimumab (Simponi Aria) Intravenous (IV) InjectionPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-070 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Glofitamab-gxbm (Columvi)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-163 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Givosiran (Givlaari) and Panhematin (Hemin)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-112 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Full-Body Computerized Tomography (CT) Scan ScreeningPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA09-012 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Filgrastim (Neupogen) and Related Biosimilars, and Tbo-filgrastim (Granix)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-130 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Fecal Microbiota Transplantation (FMT)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-006 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Fam-trastuzumab deruxtecan-nxki (Enhertu)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-114 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Facility Reporting of Observation ServicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-040B-44F8E78709 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Eye Prostheses and Scleral Cover ShellPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-050 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Extraction of Bony Impacted Teeth and Exposure of Impacted TeethPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA04-002 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal ConditionsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-087 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | External Infusion PumpsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-060 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | External Breast ProsthesesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-033 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Experimental/Investigational ServicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-005 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Evinacumab-dgnb (Evkeeza)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-133 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | eviCore Lab ManagementPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-034U-B4BD9C1778 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Evaluation and Treatment of Erectile Dysfunction (ED)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-079 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Erythropoiesis Stimulating Agents (ESAs)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-011 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Eptinezumab-jjmr (VYEPTI)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-116 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Epcoritamab-bysp (EPKINLY)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-165 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Enzyme Replacement Therapy for Mucopolysaccharidosis (e.g., Aldurazyme, Elaprase, Vimizim, Naglazyme, Mepsevii, etc.)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-034 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Enzyme Replacement for the Treatment of Gaucher's DiseasePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-023 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Enteral Nutritional TherapyPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-003 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Enfortumab vedotin-ejfv (Padcev)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-113 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Endovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal LesionsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-062 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Endovascular Grafts for Abdominal Aortic Aneurysms (AAA), Aorto-Iliac Aneurysms, and Infrarenal Aortic AneurysmsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-012 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Endoscopic Submucosal Dissection (ESD)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-118-1F3BB60FBF | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Endometrial AblationPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-065 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Emapalumab-lzsg (Gamifant)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-104 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Elranatamab-bcmm (Elrexfio)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-168 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic StudiesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-050 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Electroconvulsive Therapy (ECT)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA14-001 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Efgartigimod alfa-fcab (Vyvgart) and efgartigimod-alfa and hyaluronidase-qvfc (Vyvgart Hytrulo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-142 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Efbemalenograstim alfa-vuxw (Ryzneuta), Eflapegrastim-xnst (Rolvedon), Pegfilgrastim (Neulasta) and Related BiosimilarsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-082 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Eculizumab (Soliris) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris) for intravenous administrationPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-044 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Durvalumab (Imfinzi) and Tremelimumab-actl (Imjudo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-123E-C351A28D4E | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Durable Medical Equipment (DME) Not Subject to a Rental to Purchase MaximumPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-028 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Durable Medical Equipment (DME)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-044 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Drug-Eluting Beads and Bland Embolization for the Treatment of Hepatic MalignanciesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-041 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Dostarlimab-gxly (Jemperli)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-136 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Dofetilide (Tikosyn) Use in the Inpatient SettingPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-021 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Direct Endoscopic Necrosectomy (DEN) for the Treatment of Pancreatic NecrosisPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-115 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Direct Access to Obstetrics/Gynecology (OB/GYN) ServicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-032 | New policy |
|---|